| Literature DB >> 24343771 |
Sherri Dudal1, Daniel Baltrukonis, Rebecca Crisino, M Jaya Goyal, Alison Joyce, Karolina Osterlund, John Smeraglia, Yoshitaka Taniguchi, Jihong Yang.
Abstract
As part of the GBC (Global Bioanalysis Consortium), the L3 assay format team has focused on reviewing common platforms used to support ligand binding assays in the detection of biotherapeutics. The following review is an overview of discussions and presentations from around the globe with a group of experts from different companies to allow an international harmonization of common practices and suggestions for different platforms. Some of the major platforms include Gyrolab, Erenna, RIA, AlphaLISA, Delfia, Immuno-PCR, Luminex, BIAcore, and ELISAs. The review is meant to support bioanalysts in taking decisions between different platforms depending on the needs of the analyte with a number of recommendations to help integration of platforms into a GLP environment.Mesh:
Substances:
Year: 2013 PMID: 24343771 PMCID: PMC3933581 DOI: 10.1208/s12248-013-9552-9
Source DB: PubMed Journal: AAPS J ISSN: 1550-7416 Impact factor: 4.009